PATENT CLAIM ANALYSIS

Application Number: 15936176
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising a drug such as a triptan (e.g. rizatriptan) and/or an NSAID (e.g. meloxicam) in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the drug for the treatment of conditions such as pain.

Claim (Index 1):
A dosage form comprising a combination of: 1) meloxicam, 2) a sulfobutyl ether \u03b2-cyclodextrin (SBE\u03b2CD), and 3) a bicarbonate, and a triptan, wherein the dosage form is an oral dosage form having a shorter T max  of meloxicam in a human being than a reference dosage form that: 1) contains the same amount of meloxicam, 2) does not contain an SBE\u03b2CD, and 3) does not contain a bicarbonate.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.48837
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15902770', '15797955', '15132130', '15049488', '14280117']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.789351563248307
- 35 USC 102 Novelty (BERT): 0.5523899278752603
- Combined Prediction Score: 0.7656553997110023
- Mean Citation Score: 318.448196
- Max Citation Score: 422.23367
- Similarity Product: 403.0029696171672

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test